温熱血液灌流システム市場：臓器タイプ、種類、エンドユーザー別-2025-2030年の世界予測

温熱血液灌流システム市場は、2023年に6,687万米ドルと評価され、2024年には7,386万米ドルに達すると予測され、CAGR 10.55%で成長し、2030年には1億3,499万米ドルに達すると予測されています。

温熱血液灌流システム（WBPS）は、臓器移植における重要な進歩であり、特に、酸素を含んだ血液で体温に維持することにより、移植用の臓器を保存することができます。WBPSの主な必要性は、生存可能な臓器に対する高い需要と、しばしば臓器の損傷につながる低温保存の限界から生じる。応用範囲は心臓、肺、肝臓、腎臓移植に及び、臓器の生存性を維持することで保存期間を延長し、移植の成果を向上させることができます。最終用途の範囲では、臓器の利用可能性と移植成功率の向上から恩恵を受ける病院と移植センターが主な対象です。WBPS市場に影響を与える主な成長要因には、臓器不全の蔓延による移植の増加、医療技術の進歩、従来の方法に対するWBPSの利点に関するヘルスケア提供者の意識の高まりなどがあります。最新のビジネスチャンスは、ヘルスケアインフラが改善され、移植技術への投資が増加している新興市場での用途拡大にあります。しかし市場は、WBPSに関連する高コスト、厳しい規制要件、システム導入における潜在的なロジスティクスの課題などの制約に直面しています。システムのコスト効率の改善、可搬性の向上、人工知能の統合による灌流プロセスの最適化など、技術革新の機会は豊富にあります。また、この技術に適用可能な臓器の種類の拡大や、臓器の生着率をさらに向上させるための再生医療との組み合わせの検討にも、調査の焦点が当てられる可能性があります。このような課題にもかかわらず、臓器移植の継続的な需要と、WBPSが従来の保存方法と比較して提供する明確な利点により、市場は成長に向かっています。企業は、この市場を活用するために、ヘルスケア機関とのパートナーシップと継続的な技術革新に注力し、費用対効果が高く、より広範な世界市場で利用可能なソリューションを確保する必要があります。

市場力学：急速に進化する温熱血液灌流システム市場の主要市場インサイトを公開

温熱血液灌流システム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界中で慢性疾患に苦しむ患者の増加
  • 輸送中の生体臓器の故障
  • 心臓移植症例の増加
• 市場抑制要因
  • 臨床試験期間の長期化と故障リスク
• 市場機会
  • 国民の臓器提供を促進する政府の取り組み
  • 固形臓器保存のための灌流システムの進歩
• 市場の課題
  • 生体臓器の需要に比べ、潜在的なドナーが利用できないこと

ポーターの5つの力：温熱血液灌流システム市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：温熱血液灌流システム市場における外部からの影響の把握

外部マクロ環境要因は、温熱血液灌流システム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析温熱血液灌流システム市場における競合情勢の把握

温熱血液灌流システム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス温熱血液灌流システム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、温熱血液灌流システム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨温熱血液灌流システム市場における成功への道筋を描く

温熱血液灌流システム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患に苦しむ患者数が増加
    • 輸送中の生体臓器の機能不全
    • 心臓移植件数の増加
  • 抑制要因
    • 臨床試験期間の延長と不具合のリスク
  • 機会
    • 国民の臓器提供を促進する政府の取り組み
    • 固形臓器保存のための灌流システムの進歩
  • 課題
    • 生体臓器の需要に比べて潜在的なドナーが不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 温熱血液灌流システム市場臓器タイプ別

• 心臓
• 肝臓
• 肺

第7章 温熱血液灌流システム市場：タイプ別

• 固定されたラボ設定
• ポータブル

第8章 温熱血液灌流システム市場：最終用途別

• 外来診療ユニット
• 救急センター
• 病院

第9章 南北アメリカの温熱血液灌流システム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の温熱血液灌流システム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの温熱血液灌流システム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bridge to Life Ltd.
• Lifeline Scientific, Inc.
• Medtronic PLC
• Organ Recovery Systems, Inc.
• OrganOx Limited
• Paragonix Technologies, Inc.
• Preservation Solutions, Inc.
• Repligen Corporation
• Spectrum Laboratory Products, Inc.
• Terumo Corporation
• TransMedics, Inc.
• Water Medical System LLC by Institut Georges Lopez
• XVIVO Perfusion AB

LIST OF FIGURES

• FIGURE 1. WARM BLOOD PERFUSION SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. WARM BLOOD PERFUSION SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. WARM BLOOD PERFUSION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. WARM BLOOD PERFUSION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. WARM BLOOD PERFUSION SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. WARM BLOOD PERFUSION SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY FIXED LAB SETTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY AMBULATORY CARE UNIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY EMERGENCY CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM WARM BLOOD PERFUSION SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. WARM BLOOD PERFUSION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. WARM BLOOD PERFUSION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

The Warm Blood Perfusion System Market was valued at USD 66.87 million in 2023, expected to reach USD 73.86 million in 2024, and is projected to grow at a CAGR of 10.55%, to USD 134.99 million by 2030.

The Warm Blood Perfusion System (WBPS) is a crucial advancement in organ transplantation, specifically in preserving organs for transplantation by maintaining them at body temperature with oxygenated blood. The primary necessity of WBPS arises from the high demand for viable organs and the limitations of cold storage, which often leads to organ damage. The application scope spans heart, lung, liver, and kidney transplants, where maintaining organ viability can extend preservation times and improve transplant outcomes. The end-use scope predominantly focuses on hospitals and transplant centers that benefit from enhanced organ availability and transplantation success rates. Key growth factors influencing the WBPS market include increasing transplants due to organ failure prevalence, advancements in medical technology, and heightened awareness among healthcare providers about the benefits of WBPS over traditional methods. The latest opportunities lie in expanding applications in emerging markets experiencing improved healthcare infrastructure and increased investment in transplantation technologies. However, the market faces limitations such as high costs associated with WBPS, stringent regulatory requirements, and potential logistical challenges in implementing the systems. Innovation opportunities abound in improving system cost efficiency, enhancing portability, and integrating artificial intelligence to optimize perfusion processes. Research could also focus on expanding the type of organs applicable for this technology, as well as exploring combinations with regenerative medicine for further improving organ viability. Despite these challenges, the market is poised for growth due to the ongoing demand for organ transplantation and the clear benefits WBPS offers over traditional preservation methods. Companies must focus on partnerships with healthcare institutions and continued innovation to capitalize on this market, ensuring solutions that are both cost-effective and accessible to broader global markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Warm Blood Perfusion System Market

The Warm Blood Perfusion System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of patients suffering from chronic diseases across the globe
  • Failure of living organs during transportation
  • Increasing number of heart transplantation cases
• Market Restraints
  • Extending the period of clinical trials and the risk of malfunctions
• Market Opportunities
  • Government initiatives to promote organ donations among the population
  • Advances in perfusion systems for solid organ preservation
• Market Challenges
  • Unavailability of potential donors as compared to the demand of living organs

Porter's Five Forces: A Strategic Tool for Navigating the Warm Blood Perfusion System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Warm Blood Perfusion System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Warm Blood Perfusion System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Warm Blood Perfusion System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Warm Blood Perfusion System Market

A detailed market share analysis in the Warm Blood Perfusion System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Warm Blood Perfusion System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Warm Blood Perfusion System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Warm Blood Perfusion System Market

A strategic analysis of the Warm Blood Perfusion System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Warm Blood Perfusion System Market, highlighting leading vendors and their innovative profiles. These include Bridge to Life Ltd., Lifeline Scientific, Inc., Medtronic PLC, Organ Recovery Systems, Inc., OrganOx Limited, Paragonix Technologies, Inc., Preservation Solutions, Inc., Repligen Corporation, Spectrum Laboratory Products, Inc., Terumo Corporation, TransMedics, Inc., Water Medical System LLC by Institut Georges Lopez, and XVIVO Perfusion AB.

Market Segmentation & Coverage

This research report categorizes the Warm Blood Perfusion System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Organ Type, market is studied across Heart, Liver, and Lungs.
• Based on Type, market is studied across Fixed Lab Setting and Portable.
• Based on End-Use, market is studied across Ambulatory Care Unit, Emergency Center, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of patients suffering from chronic diseases across the globe
    • 5.1.1.2. Failure of living organs during transportation
    • 5.1.1.3. Increasing number of heart transplantation cases
  • 5.1.2. Restraints
    • 5.1.2.1. Extending the period of clinical trials and the risk of malfunctions
  • 5.1.3. Opportunities
    • 5.1.3.1. Government initiatives to promote organ donations among the population
    • 5.1.3.2. Advances in perfusion systems for solid organ preservation
  • 5.1.4. Challenges
    • 5.1.4.1. Unavailability of potential donors as compared to the demand of living organs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Warm Blood Perfusion System Market, by Organ Type

• 6.1. Introduction
• 6.2. Heart
• 6.3. Liver
• 6.4. Lungs

7. Warm Blood Perfusion System Market, by Type

• 7.1. Introduction
• 7.2. Fixed Lab Setting
• 7.3. Portable

8. Warm Blood Perfusion System Market, by End-Use

• 8.1. Introduction
• 8.2. Ambulatory Care Unit
• 8.3. Emergency Center
• 8.4. Hospital

9. Americas Warm Blood Perfusion System Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Warm Blood Perfusion System Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Warm Blood Perfusion System Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bridge to Life Ltd.
• 2. Lifeline Scientific, Inc.
• 3. Medtronic PLC
• 4. Organ Recovery Systems, Inc.
• 5. OrganOx Limited
• 6. Paragonix Technologies, Inc.
• 7. Preservation Solutions, Inc.
• 8. Repligen Corporation
• 9. Spectrum Laboratory Products, Inc.
• 10. Terumo Corporation
• 11. TransMedics, Inc.
• 12. Water Medical System LLC by Institut Georges Lopez
• 13. XVIVO Perfusion AB